Business
Todos Medical Supports Long COVID Awareness Day
Todos Medical Supports Long COVID Awareness Day.
About this update from Todos Medical Ltd.
[{"type":"text","content":"\n NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced its support for International Long COVID Awareness Day.  Todos Medical is fully aligned with the Long COVID community and its effort to boost awareness, as well as calls for additional resources to be invested to fight this potentially debilitating condition. Social media platforms around the world are hosting special online events, highlighting the impact this disease has had on everyday living.  The hashtags #LongCovid and #LongCovidAwarenessDay are being circulated to facilitate much needed dialogue on the topic. “There are tens of millions of people affected by Long COVID syndrome, post-acute sequelae of COVID cardiovascular events, and let us not forget the tremendous toll these conditions have had on caretakers and families worldwide,” said Gerald E. Commissiong, President & CEO of Todos Medical. “Long COVID is a mass disabling event that must remain at the forefront of the collective pandemic response as governments worldwide attempt to move beyond the current pandemic stage.  Something needs to be done, and here at Todos we are seeking to take a leadership role in advancing real world solutions.  We have published market research studies and several meaningful case studies that strongly suggest viral persistence is a key driver of Long COVID syndrome. We are seeking to open a prospective study to confirm the usefulness of our dietary supplement Tollovid in helping patients with the condition. Collectively, the Long COVID community needs to continue to push for action and educate people about the risks of Long COVID, as well as provide the support and advocacy needed for Long COVID patients.” Market research study on Tollovid: https://www.researchgate.net/publication/362791461_VALUE_OF_3CL_PROTEASE_INHIBITOR_SUPPLEMENTATION_1_The_Value_of_3CL_Protease_Inhibitor_Supplementation_in_Long_Haul_Syndrome_Patients_The_Value_of_3CL_Protease_Inhibitor_Supplementation_in_Long_Haul_Sy Tollovid case studies: https://www.researchgate.net/search/publication?q=tollovid For more information, please visit todosmedical.com. For more information on the Company̵...